These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24810004)

  • 21. An integrity assay for a meningococcal type B conjugate vaccine.
    Turula VE; Kim J; Michon F; Pankratz J; Zhang Y; Yoo C
    Anal Biochem; 2004 Apr; 327(2):261-70. PubMed ID: 15051544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y.
    Chanteau S; Dartevelle S; Mahamane AE; Djibo S; Boisier P; Nato F
    PLoS Med; 2006 Sep; 3(9):e337. PubMed ID: 16953658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims.
    Memish ZA; Yezli S; Almasri M; Assiri A; Turkestani A; Findlow H; Bai X; Borrow R
    Int J Infect Dis; 2014 Nov; 28():171-5. PubMed ID: 25307887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunisation update: Meningococcal B and ACWY vaccines.
    Davidson GT; Heaton PA; Paul SP
    J Fam Health; 2015; 25(6):22-5. PubMed ID: 26749934
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines.
    Tontini M; Berti F; Romano MR; Proietti D; Zambonelli C; Bottomley MJ; De Gregorio E; Del Giudice G; Rappuoli R; Costantino P; ; Brogioni G; Balocchi C; Biancucci M; Malito E
    Vaccine; 2013 Oct; 31(42):4827-33. PubMed ID: 23965218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135.
    Bardotti A; Averani G; Berti F; Berti S; Galli C; Giannini S; Fabbri B; Proietti D; Ravenscroft N; Ricci S
    Vaccine; 2005 Mar; 23(16):1887-99. PubMed ID: 15734061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding prevention of invasive meningococcal disease.
    Pelton SI; Gilmet GP
    Expert Rev Vaccines; 2009 Jun; 8(6):717-27. PubMed ID: 19485753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay.
    de Voer RM; Schepp RM; Versteegh FG; van der Klis FR; Berbers GA
    Clin Vaccine Immunol; 2009 Mar; 16(3):433-6. PubMed ID: 19129470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of meningococcal polysaccharides by capillary zone electrophoresis.
    Lamb DH; Lei QP; Hakim N; Rizzo S; Cash P
    Anal Biochem; 2005 Mar; 338(2):263-9. PubMed ID: 15745746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meningococcal vaccines.
    Danzig L
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S285-92. PubMed ID: 15597071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135.
    Lal G; Balmer P; Joseph H; Dawson M; Borrow R
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):272-9. PubMed ID: 15013975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determining trace amounts and the origin of formaldehyde impurity in Neisseria meningitidis A/C/Y/W-135-DT conjugate vaccine formulated in isotonic aqueous 1× PBS by improved C18-UPLC method.
    Gudlavalleti SK; Crawford EN; Tran NN; Orten DJ; Harder JD; Reddy JR
    J Pharm Biomed Anal; 2015 Mar; 107():432-6. PubMed ID: 25668795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
    Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
    Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
    Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.
    Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M
    Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
    Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
    J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meningococcal X polysaccharide quantification by high-performance anion-exchange chromatography using synthetic N-acetylglucosamine-4-phosphate as standard.
    Micoli F; Adamo R; Proietti D; Gavini M; Romano MR; MacLennan CA; Costantino P; Berti F
    Anal Biochem; 2013 Nov; 442(2):259-61. PubMed ID: 23938776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.